A Review of Topical Sirolimus for the Treatment of Facial Angiofibromas in Tuberous Sclerosis Complex.
Diem-Phuong D DaoJessica N PixleyZeynep M AkkurtSteven Richard FeldmanPublished in: The Annals of pharmacotherapy (2023)
Topical sirolimus 0.2% gel is a moderately effective treatment for TSC-associated facial angiofibromas with an adequate safety profile.
Keyphrases